Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. And�n, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol. 11, 303?314 (1970)
2. Bartholini, G., Pletscher, A.: Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase. J. Pharmacol. Exp. Ther. 161, 14?20 (1968)
3. Braestrup, C., Scheel-Kr�ger, J.: Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984) Eur. J. Pharmacol. 38, 305?312 (1976)
4. Buus Lassen, J.: Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4,?-dimethyl-m-tyramine (H 77/77) in rats. Psychopharmacologia (Berl.) 37, 331?340 (1974)
5. Buus Lassen, J.: Inhibition of 4,?-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chlorpromazine, haloperidol, clozapine and thioridazine. Psychopharmacologia (Berl.) 43, 25?29 (1975)